ALS drug gets backing by FDA panel after rare 2nd review

Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.

Related Keywords

China ,Cambridge ,Cambridgeshire ,United Kingdom ,Washington ,United States ,Massachusetts ,Chinese ,Amylyx Pharma ,Lou Gehrig ,Justin Klee ,Joshua Cohen ,Caleb Alexander ,Tristan Massie ,Billy Dunn ,Johns Hopkins University ,Indiana University School Of Medicine ,National Institutes Of Health ,Drug Administration ,Liana Apostolova ,Indiana University ,Dean Follmann ,National Institutes ,Greg Canter ,